Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
62000,,,5152956,[],CHEMBL1662390,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to TTA substituted qnrC gene by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
62001,,,5152957,[],CHEMBL1662391,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATT to ATG substituted qnrC gene by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
62002,,,5152958,[],CHEMBL1662392,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATT to TTA substituted qnrC gene by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
62003,,,5152959,[],CHEMBL1662393,Antimicrobial activity against Escherichia coli ATCC 25922 by CLSI agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649187,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326067,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
62004,,,5153268,[],CHEMBL1661215,Antimicrobial activity against Mycoplasma pneumoniae isolated from human by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.125
62005,,,5153315,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326464,>=,1,1,>=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
62006,,,5153329,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326464,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,2.0
62007,,,5153343,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326464,>=,1,1,>=,,MIC90,ug.mL-1,,64.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,64.0
62008,,,5153359,[],CHEMBL1666521,Antimicrobial activity against ESBL-producing Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.03
62009,,,5153366,[],CHEMBL1666522,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
62010,,,5153373,[],CHEMBL1666523,Antimicrobial activity against AmpC-depressed Enterobacter cloacae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.03
62011,,,5153380,[],CHEMBL1666524,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
62012,,,5153391,[],CHEMBL1666521,Antimicrobial activity against ESBL-producing Escherichia coli by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.06
62013,,,5153398,[],CHEMBL1666522,Antimicrobial activity against ESBL-producing Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,>,1,0,>,,MBC,ug ml-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,ug ml-1,UO_0000274,,0.25
62014,,,5153405,[],CHEMBL1666523,Antimicrobial activity against AmpC-depressed Enterobacter cloacae by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MBC,ug ml-1,UO_0000274,,0.03
62015,,,5153412,[],CHEMBL1666524,Antimicrobial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,0.5
62016,,,5153423,[],CHEMBL1666529,Antimicrobial activity against Escherichia coli isolate 5401 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
62017,,,5153430,[],CHEMBL1666530,Antimicrobial activity against Escherichia coli isolate 5411 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62018,,,5153439,[],CHEMBL1666685,Antimicrobial activity against Klebsiella pneumoniae isolate 5427 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
62019,,,5153446,[],CHEMBL1666686,Antimicrobial activity against Klebsiella pneumoniae isolate 5436 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
62020,,,5153455,[],CHEMBL1666689,Antimicrobial activity against Enterobacter cloacae isolate 4073 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
62021,,,5153462,[],CHEMBL1666690,Antimicrobial activity against Enterobacter cloacae isolate 5420 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.06
62022,,,5153471,[],CHEMBL1666693,Antimicrobial activity against Pseudomonas aeruginosa isolate 796 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
62023,,,5153478,[],CHEMBL1666694,Antimicrobial activity against Pseudomonas aeruginosa isolate 956 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
62024,,,5153485,[],CHEMBL1666695,Antimicrobial activity against Pseudomonas aeruginosa isolate 1019 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
62025,,,5153492,[],CHEMBL1666696,Antimicrobial activity against Pseudomonas aeruginosa isolate 1037 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
62026,,,5153503,[],CHEMBL1666529,Antimicrobial activity against Escherichia coli isolate 5401 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,32.0
62027,,,5153510,[],CHEMBL1666530,Antimicrobial activity against Escherichia coli isolate 5411 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,16.0
62028,,,5153519,[],CHEMBL1666685,Antimicrobial activity against Klebsiella pneumoniae isolate 5427 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,ug ml-1,UO_0000274,,2.0
62029,,,5153526,[],CHEMBL1666686,Antimicrobial activity against Klebsiella pneumoniae isolate 5436 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MBC,ug ml-1,UO_0000274,,4.0
62030,,,5153535,[],CHEMBL1666689,Antimicrobial activity against Enterobacter cloacae isolate 4073 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MBC,ug ml-1,UO_0000274,,0.06
62031,,,5153542,[],CHEMBL1666690,Antimicrobial activity against Enterobacter cloacae isolate 5420 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MBC,ug ml-1,UO_0000274,,0.06
62032,,,5153551,[],CHEMBL1666693,Antimicrobial activity against Pseudomonas aeruginosa isolate 796 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,2.0
62033,,,5153558,[],CHEMBL1666694,Antimicrobial activity against Pseudomonas aeruginosa isolate 956 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,1.0
62034,,,5153565,[],CHEMBL1666695,Antimicrobial activity against Pseudomonas aeruginosa isolate 1019 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,1.0
62035,,,5153572,[],CHEMBL1666696,Antimicrobial activity against Pseudomonas aeruginosa isolate 1037 by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326479,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,0.5
62036,,Not Active,5153583,[],CHEMBL1666701,Bactericidal activity against Pseudomonas aeruginosa isolate 796 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,,Inhibition,%,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,INH,,UO_0000187,,
62037,,Not Active,5153590,[],CHEMBL1666702,Bactericidal activity against Pseudomonas aeruginosa isolate 956 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,,Inhibition,%,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,INH,,UO_0000187,,
62038,,Not Active,5153597,[],CHEMBL1666703,Bactericidal activity against Pseudomonas aeruginosa isolate 1019 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,,Inhibition,%,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,INH,,UO_0000187,,
62039,,Not Active,5153604,[],CHEMBL1666704,Bactericidal activity against Pseudomonas aeruginosa isolate 1037 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,,Inhibition,%,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,INH,,UO_0000187,,
62040,,Not Active,5153611,[],CHEMBL1666705,Bactericidal activity against Enterobacter cloacae isolate 4073 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,,Inhibition,%,,,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,INH,,UO_0000187,,
62041,,Not Active,5153618,[],CHEMBL1666706,Bactericidal activity against Enterobacter cloacae isolate 5420 at 1/4 times MIC after 24 hrs by time kill analysis,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649465,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326479,,1,0,,,Inhibition,%,,,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,INH,,UO_0000187,,
62042,,,5154314,[],CHEMBL1662077,"Antibacterial activity against Helicobacter pylori infected in human assessed as bacterial eradication rate at 500 mg, po BID for 10 days by 13C-urea breath test",F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1325736,=,1,0,=,,Activity,%,,66.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,%,UO_0000187,,66.0
62043,,,5154334,[],CHEMBL1662077,"Antibacterial activity against Helicobacter pylori infected in human assessed as bacterial eradication rate at 500 mg, po BID for 10 days by 13C-urea breath test",F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649149,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325736,=,1,0,=,,Activity,mg,,500.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,mg,UO_0000022,,500.0
62044,,,5154347,[],CHEMBL1661216,Antimicrobial activity against Mycoplasma genitalium isolated from human by two fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.125
62045,,,5154353,[],CHEMBL1661219,Antimicrobial activity against Ureaplasma parvum isolated from human by two fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.125
62046,,,5154359,[],CHEMBL1661220,Antimicrobial activity against Ureaplasma urealyticum isolated from human by two fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.5
62047,,,5154365,[],CHEMBL1661215,Antimicrobial activity against Mycoplasma pneumoniae isolated from human by two fold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62048,,,5154371,[],CHEMBL1661219,Antimicrobial activity against Ureaplasma parvum isolated from human by two fold serial dilution method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
62049,,,5154377,[],CHEMBL1661220,Antimicrobial activity against Ureaplasma urealyticum isolated from human by two fold serial dilution method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
62050,,,5154383,[],CHEMBL1661215,Antimicrobial activity against Mycoplasma pneumoniae isolated from human by two fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62051,,,5154389,[],CHEMBL1661219,Antimicrobial activity against Ureaplasma parvum isolated from human by two fold serial dilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,2.0
62052,,,5154395,[],CHEMBL1661220,Antimicrobial activity against Ureaplasma urealyticum isolated from human by two fold serial dilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
62053,,,5154402,[],CHEMBL1661217,Antimicrobial activity against Mycoplasma fermentans isolated from human by two fold serial dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.008
62054,,,5154409,[],CHEMBL1661218,Antimicrobial activity against Mycoplasma hominis isolated from human by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC,ug ml-1,UO_0000274,,0.125
62055,,,5154416,[],CHEMBL1661217,Antimicrobial activity against Mycoplasma fermentans isolated from human by two fold serial dilution method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC50,ug.mL-1,,0.031,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.031
62056,,,5154423,[],CHEMBL1661218,Antimicrobial activity against Mycoplasma hominis isolated from human by two fold serial dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62057,,,5154430,[],CHEMBL1661217,Antimicrobial activity against Mycoplasma fermentans isolated from human by two fold serial dilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC90,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.125
62058,,,5154437,[],CHEMBL1661218,Antimicrobial activity against Mycoplasma hominis isolated from human by two fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649196,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326122,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62059,,,5155447,[],CHEMBL1662942,"Drug excretion in pyelonephritis patient urine at 250 mg/kg, iv administered every 24 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1325741,=,1,0,=,,Activity,%,,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,80.0
62060,,,5155448,[],CHEMBL1662943,"Drug excretion in pyelonephritis patient urine at 500 mg/kg, iv administered every 8 hrs",A,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1325741,=,1,0,=,,Activity,%,,80.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Activity,%,UO_0000187,,80.0
62061,,,5155449,[],CHEMBL1662944,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,1.0
62062,,,5155450,[],CHEMBL1662945,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,64.0
62063,,,5155451,[],CHEMBL1662947,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,2.0
62064,,,5155452,[],CHEMBL1662948,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,16.0
62065,,,5155453,[],CHEMBL1662949,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,32.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Time,hr,UO_0000032,,32.0
62066,,,5155454,[],CHEMBL1663083,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,256.0
62067,,,5155455,[],CHEMBL1662950,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,64.0
62068,,,5155456,[],CHEMBL1663087,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,256.0
62069,,,5155457,[],CHEMBL1663084,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62070,,,5155458,[],CHEMBL1663088,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,128.0
62071,,,5155459,[],CHEMBL1663090,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,0.0
62072,,,5155460,[],CHEMBL1663092,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,2.0
62073,,,5155461,[],CHEMBL1663091,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62074,,,5155462,[],CHEMBL1663093,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62075,,,5155463,[],CHEMBL1663095,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,2.0
62076,,,5155464,[],CHEMBL1663096,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,64.0
62077,,,5155465,[],CHEMBL1663099,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,128.0
62078,,,5155466,[],CHEMBL1663098,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
62079,,,5155467,[],CHEMBL1663101,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,128.0
62080,,,5155468,[],CHEMBL1663100,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,32.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Time,hr,UO_0000032,,32.0
62081,,,5155469,[],CHEMBL1661310,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,512.0
62082,,,5155470,[],CHEMBL1661312,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62083,,,5155471,[],CHEMBL1661315,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,1024.0
62084,,,5155472,[],CHEMBL1661316,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,256.0
62085,,,5155473,[],CHEMBL1661318,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,0.0
62086,,,5155474,[],CHEMBL1661319,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62087,,,5155475,[],CHEMBL1661320,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,2.0
62088,,,5155476,[],CHEMBL1661321,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62089,,,5155477,[],CHEMBL1661323,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,4.0
62090,,,5155478,[],CHEMBL1661324,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,128.0
62091,,,5155479,[],CHEMBL1661326,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
62092,,,5155480,[],CHEMBL1661327,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,128.0
62093,,,5155481,[],CHEMBL1661328,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Time,hr,UO_0000032,,128.0
62094,,,5155482,[],CHEMBL1661329,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,256.0
62095,,,5155483,[],CHEMBL1661334,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,1024.0
62096,,,5155484,[],CHEMBL1661336,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4096.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,4096.0
62097,,,5155485,[],CHEMBL1661460,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,1024.0
62098,,,5155486,[],CHEMBL1661339,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,128.0
62099,,,5155487,[],CHEMBL1661462,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,0.0
62100,,,5155488,[],CHEMBL1661463,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62101,,,5155641,[],CHEMBL1661719,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,0.25
62102,,,5155643,[],CHEMBL1661718,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,4.0
62103,,,5155644,[],CHEMBL1661716,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,16.0
62104,,,5155645,[],CHEMBL1661717,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,mg/L,UO_0000274,,8.0
62105,,,5155646,[],CHEMBL1661715,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,4.0
62106,,,5155647,[],CHEMBL1661714,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,8.0
62107,,,5155648,[],CHEMBL1661712,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.125
62108,,,5155649,[],CHEMBL1661713,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg/L,UO_0000274,,1.0
62109,,Not Determined,5155650,[],CHEMBL1661711,Antimicrobial activity against Staphylococcus haemolyticus 1949819 B-M isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325741,,1,0,,,MIC,,,,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,,,,
62110,,,5155651,[],CHEMBL1661709,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg/L,UO_0000274,,32.0
62111,,,5155652,[],CHEMBL1661710,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,32.0
62112,,,5155653,[],CHEMBL1661708,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mg/L,UO_0000274,,32.0
62113,,,5155654,[],CHEMBL1661707,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62114,,Not Determined,5155655,[],CHEMBL1661706,Antimicrobial activity against Escherichia coli 2297257 B-W isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325741,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
62115,,,5155656,[],CHEMBL1661704,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.047
62116,,,5155657,[],CHEMBL1661705,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.047
62117,,Not Determined,5155658,[],CHEMBL1661702,Antimicrobial activity against Escherichia coli 1821385 B-C isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325741,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
62118,,Not Determined,5155659,[],CHEMBL1661703,Antimicrobial activity against Escherichia coli 1780063 B-A isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325741,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
62119,,,5155660,[],CHEMBL1661700,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.03
62120,,,5155661,[],CHEMBL1661699,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.03
62121,,,5155662,[],CHEMBL1661701,Antimicrobial activity against Escherichia coli 1889646 B-F isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,8.0
62122,,Not Determined,5155663,[],CHEMBL1661698,Antimicrobial activity against Escherichia coli 1889645 B-I isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325741,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
62123,,,5155664,[],CHEMBL1661697,Antimicrobial activity against Escherichia coli 1949825 B-K isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.03
62124,,Not Determined,5155665,[],CHEMBL1661695,Antimicrobial activity against Escherichia coli 1949826 B-L isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325741,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
62125,,,5155666,[],CHEMBL1661696,Antimicrobial activity against Escherichia coli 2062717 B-P isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,8.0
62126,,,5155667,[],CHEMBL1661694,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.032
62127,,,5155668,[],CHEMBL1661691,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,0.25
62128,,,5155669,[],CHEMBL1661693,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,mg/L,UO_0000274,,0.19
62129,,,5155670,[],CHEMBL1661692,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,0.06
62130,,,5155671,[],CHEMBL1661689,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.06
62131,,Not Determined,5155672,[],CHEMBL1661690,Antimicrobial activity against Enterococcus faecalis 2215770 B-T isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325741,,1,0,,,MIC,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,,,,
62132,,,5155673,[],CHEMBL1661688,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325741,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,8.0
62133,,,5155674,[],CHEMBL1661687,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,16.0
62134,,,5155675,[],CHEMBL1661685,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,8.0
62135,,,5155676,[],CHEMBL1661555,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,2.0
62136,,,5155677,[],CHEMBL1661686,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Time,hr,UO_0000032,,0.0
62137,,,5155678,[],CHEMBL1660829,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,8.0
62138,,,5155679,[],CHEMBL1660827,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,32.0
62139,,,5155680,[],CHEMBL1660828,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,4.0
62140,,,5155681,[],CHEMBL1660826,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,192.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,192.0
62141,,,5155682,[],CHEMBL1660824,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,8.0
62142,,,5155683,[],CHEMBL1660825,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,16.0
62143,,,5155684,[],CHEMBL1660822,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Time,hr,UO_0000032,,0.0
62144,,,5155685,[],CHEMBL1660823,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,2.0
62145,,,5155686,[],CHEMBL1660821,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,4.0
62146,,,5155687,[],CHEMBL1660819,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,16.0
62147,,,5155688,[],CHEMBL1660820,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2.0
62148,,,5155689,[],CHEMBL1660818,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,128.0
62149,,,5155690,[],CHEMBL1660817,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,8.0
62150,,,5155691,[],CHEMBL1660816,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,3.0
62151,,,5155692,[],CHEMBL1660815,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Time,hr,UO_0000032,,0.0
62152,,,5155693,[],CHEMBL1660814,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,1.0
62153,,,5155694,[],CHEMBL1660813,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,4.0
62154,,,5155695,[],CHEMBL1660812,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,0.5
62155,,,5155696,[],CHEMBL1660676,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,64.0
62156,,,5155697,[],CHEMBL1660677,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,16.0
62157,,,5155698,[],CHEMBL1660675,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,8.0
62158,,,5155699,[],CHEMBL1660674,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2.5
62159,,,5155700,[],CHEMBL1660673,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Time,hr,UO_0000032,,0.0
62160,,,5155701,[],CHEMBL1660672,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,1.0
62161,,,5155702,[],CHEMBL1660670,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,4.0
62162,,,5155703,[],CHEMBL1660671,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,0.5
62163,,,5155704,[],CHEMBL1660669,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,16.0
62164,,,5155705,[],CHEMBL1660668,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
62165,,,5155706,[],CHEMBL1660667,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,6.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,6.0
62166,,,5155707,[],CHEMBL1660666,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,3.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,3.0
62167,,,5155708,[],CHEMBL1660664,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,1.0
62168,,,5155709,[],CHEMBL1660665,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Time,hr,UO_0000032,,0.0
62169,,,5155710,[],CHEMBL1660663,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,2.0
62170,,,5155711,[],CHEMBL1660662,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,1.0
62171,,,5155712,[],CHEMBL1660661,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,8.0
62172,,,5155713,[],CHEMBL1660660,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 20 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,48.0
62173,,,5155714,[],CHEMBL1660657,Antimicrobial activity against Escherichia coli 1135121 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2.0
62174,,,5155715,[],CHEMBL1660659,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
62175,,,5155716,[],CHEMBL1660658,Antimicrobial activity against Proteus mirabilis 1134841 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Time,hr,UO_0000032,,0.0
62176,,,5155717,[],CHEMBL1660656,Antimicrobial activity against Pseudomonas aeruginosa 1134642 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,0.0
62177,,,5155718,[],CHEMBL1660655,Antimicrobial activity against Staphylococcus aureus 1134684 isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,2.0
62178,,,5155719,[],CHEMBL1660654,Antimicrobial activity against Escherichia coli 1949820 B-N isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,0.0
62179,,,5155720,[],CHEMBL1660653,Antimicrobial activity against Enterococcus faecalis 1780065 B-B isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,6.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,6.0
62180,,,5155721,[],CHEMBL1660652,Antimicrobial activity against Escherichia coli 1949821 B-M isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,40.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,40.0
62181,,,5155722,[],CHEMBL1660649,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,1.0
62182,,,5155723,[],CHEMBL1660650,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62183,,,5155724,[],CHEMBL1660648,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62184,,,5155725,[],CHEMBL1660647,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,0.0
62185,,,5155726,[],CHEMBL1660645,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,1024.0
62186,,,5155727,[],CHEMBL1660644,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62187,,,5155728,[],CHEMBL1662434,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62188,,,5155729,[],CHEMBL1662433,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62189,,,5155730,[],CHEMBL1662427,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1024.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,1024.0
62190,,,5155731,[],CHEMBL1662426,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,512.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Time,hr,UO_0000032,,512.0
62191,,,5155732,[],CHEMBL1662425,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,32.0
62192,,,5155733,[],CHEMBL1662300,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,8.0
62193,,,5155734,[],CHEMBL1662298,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,256.0
62194,,,5155735,[],CHEMBL1662297,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 4 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,4.0
62195,,,5155736,[],CHEMBL1662295,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62196,,,5155737,[],CHEMBL1662294,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,1.0
62197,,,5155738,[],CHEMBL1662293,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62198,,,5155739,[],CHEMBL1662292,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,0.0
62199,,,5155740,[],CHEMBL1662290,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,512.0
62200,,,5155741,[],CHEMBL1662289,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62201,,,5155742,[],CHEMBL1662285,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,8192.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,8192.0
62202,,,5155743,[],CHEMBL1662284,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62203,,,5155744,[],CHEMBL1662279,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,512.0
62204,,,5155745,[],CHEMBL1662278,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,256.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Time,hr,UO_0000032,,256.0
62205,,,5155746,[],CHEMBL1662277,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,128.0
62206,,,5155747,[],CHEMBL1662276,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
62207,,,5155748,[],CHEMBL1662274,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,128.0
62208,,,5155749,[],CHEMBL1662273,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 8 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,4.0
62209,,,5155750,[],CHEMBL1662271,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62210,,,5155751,[],CHEMBL1662270,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,4.0
62211,,,5155752,[],CHEMBL1662269,Antimicrobial activity against Enterococcus faecalis 2215767-10 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,1.0
62212,,,5155753,[],CHEMBL1662268,Antimicrobial activity against Staphylococcus aureus 2215767-9 B-S isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,1.0
62213,,,5155754,[],CHEMBL1662266,Antimicrobial activity against Escherichia coli 1780064 A-X isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,256.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,256.0
62214,,,5155755,[],CHEMBL1662154,Antimicrobial activity against Escherichia coli 1655646 A-Y isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62215,,,5155756,[],CHEMBL1662151,Antimicrobial activity against Escherichia coli 1821386 B-D isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2048.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,2048.0
62216,,,5155757,[],CHEMBL1661477,Antimicrobial activity against Escherichia coli 1889647 B-H isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,512.0
62217,,,5155758,[],CHEMBL1661473,Antimicrobial activity against Escherichia coli 2062716 B-R isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Time,hr,UO_0000032,,512.0
62218,,,5155759,[],CHEMBL1661472,Antimicrobial activity against Serratia marcescens 2297260 B-U isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Time,hr,UO_0000032,,128.0
62219,,,5155760,[],CHEMBL1661471,Antimicrobial activity against Pseudomonas aeruginosa 1821383 B-E isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,128.0
62220,,,5155761,[],CHEMBL1661470,Antimicrobial activity against Pseudomonas aeruginosa 2062713 B-Q isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Time,hr,UO_0000032,,4.0
62221,,,5155762,[],CHEMBL1661468,Antimicrobial activity against Staphylococcus aureus 1889640 A-Z isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Time,hr,UO_0000032,,128.0
62222,,,5155763,[],CHEMBL1661467,Antimicrobial activity against Staphylococcus epidermidis 1949822 B-J isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 12 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,2.0
62223,,,5155764,[],CHEMBL1661465,Antimicrobial activity against Enterococcus faecalis 2297262-10 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Time,hr,UO_0000032,,0.0
62224,,,5155765,[],CHEMBL1661464,Antimicrobial activity against Staphylococcus epidermidis 2297262-9 B-V isolated from patient with pyelonephritis assessed as >3-log reduction in urinary bacterial titer after 16 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649151,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Hour,1325741,=,1,1,=,,TIME,hr,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Time,hr,UO_0000032,,2.0
62225,,,5156464,[],CHEMBL1666604,Antimicrobial activity against Clostridium difficile C253 expressing tcdA and tcdB gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62226,,,5156465,[],CHEMBL1666605,"Antimicrobial activity against Clostridium difficile CD25 expressing tcdA, tcdB gene and GyrB Ser416Ala mutant by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62227,,,5156466,[],CHEMBL1666606,Antimicrobial activity against Clostridium difficile A422 expressing tcdA and tcdB gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62228,,,5156467,[],CHEMBL1666607,Antimicrobial activity against Clostridium difficile 630 expressing tcdA and tcdB gene by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62229,,,5156468,[],CHEMBL1667325,Antimicrobial activity against Clostridium difficile BI2 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62230,,,5156469,[],CHEMBL1667331,Antimicrobial activity against Clostridium difficile C253a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62231,,,5156470,[],CHEMBL1667332,Antimicrobial activity against Clostridium difficile C253b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62232,,,5156471,[],CHEMBL1667333,Antimicrobial activity against Clostridium difficile C253c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62233,,,5156472,[],CHEMBL1667337,Antimicrobial activity against Clostridium difficile C253d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62234,,,5156473,[],CHEMBL1667459,Antimicrobial activity against Clostridium difficile C253e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62235,,,5156474,[],CHEMBL1667460,Antimicrobial activity against Clostridium difficile C253f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62236,,,5156475,[],CHEMBL1667464,Antimicrobial activity against Clostridium difficile C253g harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62237,,,5156476,[],CHEMBL1667465,Antimicrobial activity against Clostridium difficile C253h harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62238,,,5156477,[],CHEMBL1667466,Antimicrobial activity against Clostridium difficile C253i harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62239,,,5156478,[],CHEMBL1667470,Antimicrobial activity against Clostridium difficile CD5a harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62240,,,5156479,[],CHEMBL1667471,Antimicrobial activity against Clostridium difficile CD5b harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62241,,,5156480,[],CHEMBL1667472,Antimicrobial activity against Clostridium difficile CD5c harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62242,,,5156481,[],CHEMBL1667476,Antimicrobial activity against Clostridium difficile CD5d harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62243,,,5156482,[],CHEMBL1667477,Antimicrobial activity against Clostridium difficile CD5e harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62244,,,5156483,[],CHEMBL1667478,Antimicrobial activity against Clostridium difficile CD5f harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62245,,,5156484,[],CHEMBL1667482,Antimicrobial activity against Clostridium difficile CD5 1-g harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
62246,,,5156485,[],CHEMBL1667483,Antimicrobial activity against Clostridium difficile CD5h harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
62247,,,5156486,[],CHEMBL1667484,Antimicrobial activity against Clostridium difficile CD5i harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,16.0
62248,,,5156487,[],CHEMBL1667488,"Antimicrobial activity against Clostridium difficile CD5 2-g harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62249,,,5156488,[],CHEMBL1667489,"Antimicrobial activity against Clostridium difficile CD5h harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62250,,,5156489,[],CHEMBL1667490,"Antimicrobial activity against Clostridium difficile CD5i harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62251,,,5156490,[],CHEMBL1667494,Antimicrobial activity against Clostridium difficile A422a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62252,,,5156491,[],CHEMBL1667495,Antimicrobial activity against Clostridium difficile A422b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62253,,,5156492,[],CHEMBL1667496,Antimicrobial activity against Clostridium difficile A422c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62254,,,5156493,[],CHEMBL1667627,Antimicrobial activity against Clostridium difficile A422d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62255,,,5156494,[],CHEMBL1667628,Antimicrobial activity against Clostridium difficile A422e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62256,,,5156495,[],CHEMBL1667629,Antimicrobial activity against Clostridium difficile A422f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62257,,,5156496,[],CHEMBL1665591,Antimicrobial activity against Clostridium difficile A422g harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62258,,,5156497,[],CHEMBL1665592,Antimicrobial activity against Clostridium difficile A422h harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62259,,,5156498,[],CHEMBL1665593,Antimicrobial activity against Clostridium difficile A422i harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62260,,,5156499,[],CHEMBL1665597,Antimicrobial activity against Clostridium difficile 630a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62261,,,5156500,[],CHEMBL1665598,Antimicrobial activity against Clostridium difficile 630b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62262,,,5156501,[],CHEMBL1665599,Antimicrobial activity against Clostridium difficile 630c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62263,,,5156502,[],CHEMBL1665603,Antimicrobial activity against Clostridium difficile 630d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62264,,,5156503,[],CHEMBL1665604,Antimicrobial activity against Clostridium difficile 630e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62265,,,5156504,[],CHEMBL1665605,Antimicrobial activity against Clostridium difficile 630f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
62266,,,5156505,[],CHEMBL1665609,Antimicrobial activity against Clostridium difficile 630g harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62267,,,5156506,[],CHEMBL1665610,Antimicrobial activity against Clostridium difficile 630h harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62268,,,5156507,[],CHEMBL1665611,Antimicrobial activity against Clostridium difficile 630i harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62269,,,5156508,[],CHEMBL1665615,Antimicrobial activity against Clostridium difficile BI2a harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,8.0
62270,,,5156509,[],CHEMBL1665616,Antimicrobial activity against Clostridium difficile BI2b harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,8.0
62271,,,5156510,[],CHEMBL1665617,Antimicrobial activity against Clostridium difficile BI2c harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,8.0
62272,,,5156511,[],CHEMBL1665621,Antimicrobial activity against Clostridium difficile BI2d harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62273,,,5156512,[],CHEMBL1665755,Antimicrobial activity against Clostridium difficile BI2e harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62274,,,5156513,[],CHEMBL1665756,Antimicrobial activity against Clostridium difficile BI2f harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,64.0
62275,,,5156514,[],CHEMBL1665760,Antimicrobial activity against Clostridium difficile C253A selected after 4 ug/ml of levofloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
62276,,,5156515,[],CHEMBL1665761,Antimicrobial activity against Clostridium difficile C253B selected after 4 ug/ml of levofloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
62277,,,5156516,[],CHEMBL1665762,Antimicrobial activity against Clostridium difficile C253C selected after 4 ug/ml of levofloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
62278,,,5156517,[],CHEMBL1665766,Antimicrobial activity against Clostridium difficile C253D selected after 8 ug/ml of levofloxacin by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326704,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
62279,,,5157370,[],CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326301,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.015
62280,,,5157380,[],CHEMBL1660791,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae ATCC 15531 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326301,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.25
62281,,,5157390,[],CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326301,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62282,,,5157400,[],CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326301,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62283,,,5158065,[],CHEMBL1655751,Antimicrobial activity against Bacteroides sp. in three-stage chemostat gut model assessed as log reduction in bacterial count at 63 mg/liter administered daily for 7 days,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325345,=,1,0,=,,FC,,,1.0,CHEMBL613908,Bacteroides sp.,Bacteroides sp.,29523.0,,,FC,,,,1.0
62284,,Not Active,5158066,[],CHEMBL1655752,Antimicrobial activity against Lactobacillus in three-stage chemostat gut model assessed as log reduction in bacterial count at 63 mg/liter administered daily for 7 days,F,,,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325345,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
62285,,Not Active,5158067,[],CHEMBL1655753,Antimicrobial activity against Clostridium in three-stage chemostat gut model assessed as log reduction in bacterial count at 63 mg/liter administered daily for 7 days,F,,,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325345,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
62286,,Not Active,5158068,[],CHEMBL1655754,Antimicrobial activity against Enterococcus in three-stage chemostat gut model assessed as log reduction in bacterial count at 63 mg/liter administered daily for 7 days,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325345,,1,0,,,Activity,,,,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,Activity,,,,
62287,,Active,5158074,[],CHEMBL1656249,Induction of cytotoxin production in Clostridium difficile PCR ribotype 027 in three-stage chemostat gut model at 63 mg/liter administered daily for 7 days measured after 2 days,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325345,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
62288,,Active,5158075,[],CHEMBL1656250,Induction of cytotoxin production in Clostridium difficile PCR ribotype 001 in three-stage chemostat gut model at 63 mg/liter administered daily for 7 days measured after 3 days,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325345,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
62289,,,5158080,[],CHEMBL1656245,Drug level in human feces,A,,,BAO_0000179,BAO_0000221,tissue-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1325345,=,1,0,=,,Drug uptake,mg Kg-1,,94.0,CHEMBL612558,,ADMET,,,,Drug uptake,mg Kg-1,UO_0000308,,94.0
62290,,,5158085,[],CHEMBL1656241,Antimicrobial activity against Clostridium difficile PCR ribotype 027 expressing gyrB Glu466Lys mutant grown on fluoroquinolone-containing medium after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325345,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,256.0
62291,,,5158086,[],CHEMBL1656242,Antimicrobial activity against Clostridium difficile PCR ribotype 001 expressing gyrB Glu466Lys mutant grown on fluoroquinolone-containing medium after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325345,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,mg/L,UO_0000274,,256.0
62292,,,5160059,[],CHEMBL1653134,Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,16.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,16.8
62293,,,5160068,[],CHEMBL1653137,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus assessed as resistant isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,5.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,5.6
62294,,,5160216,[],CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.5
62295,,,5160226,[],CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
62296,,,5160236,[],CHEMBL1654553,Antibacterial activity against Beta-hemolytic Streptococcus group B by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,ug ml-1,UO_0000274,,0.25
62297,,,5160245,[],CHEMBL1653759,Antibacterial activity against Beta-hemolytic Streptococcus group A by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC,ug ml-1,UO_0000274,,0.25
62298,,,5161310,[],CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
62299,,,5161319,[],CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
62300,,,5161329,[],CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62301,,,5161339,[],CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62302,,,5161349,[],CHEMBL1654553,Antibacterial activity against Beta-hemolytic Streptococcus group B by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62303,,,5161358,[],CHEMBL1653759,Antibacterial activity against Beta-hemolytic Streptococcus group A by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62304,,,5161366,[],CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62305,,,5161375,[],CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62306,,,5161385,[],CHEMBL1654555,Antibacterial activity against Enterococcus faecium by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,,MIC50,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,4.0
62307,,,5161395,[],CHEMBL1654554,Antibacterial activity against Enterococcus faecalis by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62308,,,5161405,[],CHEMBL1654553,Antibacterial activity against Beta-hemolytic Streptococcus group B by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62309,,,5161414,[],CHEMBL1653759,Antibacterial activity against Beta-hemolytic Streptococcus group A by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62310,,,5161422,[],CHEMBL1653758,Antibacterial activity against Methicillin-resistant Staphylococcus aureus by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,>,1,1,>,,MIC50,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,4.0
62311,,,5161431,[],CHEMBL1653757,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus by CLSI broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326353,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62312,,,5161447,[],CHEMBL1653129,Antibacterial activity against Methicillin-resistant Staphylococcus aureus assessed as resistant isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,82.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,82.4
62313,,,5161456,[],CHEMBL1653127,Antibacterial activity against Methicillin-sensitive Staphylococcus aureus assessed as susceptible isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,94.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,94.2
62314,,,5161464,[],CHEMBL1653013,Antibacterial activity against Beta-hemolytic Streptococcus group A assessed as susceptible isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,100.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,Activity,%,UO_0000187,,100.0
62315,,,5161473,[],CHEMBL1653011,Antibacterial activity against Beta-hemolytic Streptococcus group A assessed as resistant isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,0.0,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,Activity,%,UO_0000187,,0.0
62316,,,5161482,[],CHEMBL1653009,Antibacterial activity against Beta-hemolytic Streptococcus group B assessed as susceptible isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,99.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,Activity,%,UO_0000187,,99.5
62317,,,5161491,[],CHEMBL1653007,Antibacterial activity against Beta-hemolytic Streptococcus group B assessed as resistant isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,Activity,%,UO_0000187,,0.5
62318,,,5161501,[],CHEMBL1653002,Antibacterial activity against Enterococcus faecalis assessed as susceptible isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,65.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,65.2
62319,,,5161511,[],CHEMBL1652999,Antibacterial activity against Enterococcus faecalis assessed as resistant isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,34.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,34.2
62320,,,5161521,[],CHEMBL1653000,Antibacterial activity against Enterococcus faecium assessed as susceptible isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,14.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,14.2
62321,,,5161531,[],CHEMBL1652997,Antibacterial activity against Enterococcus faecium assessed as resistant isolates by CLSI broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649441,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1326353,=,1,0,=,,Activity,%,,82.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,82.2
62322,,,5162740,[],CHEMBL1665066,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
62323,,,5162741,[],CHEMBL1665067,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
62324,,,5162742,[],CHEMBL1665784,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
62325,,,5162743,[],CHEMBL1665785,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
62326,,,5162744,[],CHEMBL1665786,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
62327,,,5162745,[],CHEMBL1665787,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
62328,,,5162746,[],CHEMBL1665788,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
62329,,,5162747,[],CHEMBL1665789,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
62330,,,5162788,[],CHEMBL1665931,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,2.0
62331,,,5162789,[],CHEMBL1665932,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,,Activity,ug ml-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,2.0
62332,,,5162790,[],CHEMBL1665933,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,16.0
62333,,,5162791,[],CHEMBL1665934,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,,Activity,ug ml-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,16.0
62334,,,5162792,[],CHEMBL1665935,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,,Activity,ug ml-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,32.0
62335,,,5162793,[],CHEMBL1665936,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,,Activity,ug ml-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,32.0
62336,,,5162837,[],CHEMBL1665937,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327008,=,1,0,=,,Activity,ug ml-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,128.0
62337,,,5162838,[],CHEMBL1665938,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327008,=,1,0,=,,Activity,%,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,128.0
62338,,,5163005,[],CHEMBL1665120,Antibacterial activity against Escherichia coli TOP10 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327030,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
62339,,,5163012,[],CHEMBL1665121,Antibacterial activity against quinolone-resistant Escherichia coli TOP10-3963 transformant harboring qnrS1 gene by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327030,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62340,,,5163019,[],CHEMBL1665119,Antibacterial activity against Escherichia coli 3963 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649536,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327030,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
62341,,,5163748,[],CHEMBL1654045,Antibacterial activity against quinolone-susceptible Bordetella pertussis CCUG 30837 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.016
62342,,,5163749,[],CHEMBL1654046,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP101 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.016
62343,,,5163750,[],CHEMBL1654047,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP106 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
62344,,,5163751,[],CHEMBL1654048,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP109 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.004
62345,,,5163752,[],CHEMBL1654049,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP111 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
62346,,,5163753,[],CHEMBL1654050,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP112 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
62347,,,5163754,[],CHEMBL1654051,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP113 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
62348,,,5163755,[],CHEMBL1654052,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP115 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.008
62349,,,5163756,[],CHEMBL1654053,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP128 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.016
62350,,,5163757,[],CHEMBL1654054,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP58 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.064
62351,,,5163758,[],CHEMBL1654055,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP99 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.064
62352,,,5163759,[],CHEMBL1654056,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP117 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.064
62353,,,5163760,[],CHEMBL1654057,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP118 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.064
62354,,,5163761,[],CHEMBL1654058,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP121 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.064
62355,,,5163762,[],CHEMBL1654059,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP122 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649508,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326829,=,1,1,=,,MIC,ug.mL-1,,0.064,CHEMBL614434,Bordetella pertussis,Bordetella pertussis,520.0,,,MIC,ug ml-1,UO_0000274,,0.064
62356,,,5164471,[],CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323848,<=,1,1,<=,,MIC50,ug.mL-1,,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC50,ug ml-1,UO_0000274,,0.008
62357,,,5164482,[],CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323848,<=,1,1,<=,,MIC90,ug.mL-1,,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC90,ug ml-1,UO_0000274,,0.008
62358,,,5164493,[],CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323848,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC,ug ml-1,UO_0000274,,0.008
62359,,,5164501,[],CHEMBL1658622,Antimicrobial activity against Neisseria meningitidis assessed as susceptible isolate by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1323848,=,1,0,=,,Activity,%,,97.1,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,Activity,%,UO_0000187,,97.1
62360,,,5164502,[],CHEMBL1658623,Antimicrobial activity against Neisseria meningitidis assessed as resistant isolate by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1323848,=,1,0,=,,Activity,%,,1.9,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,Activity,%,UO_0000187,,1.9
62361,,,5165433,[],CHEMBL1657977,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
62362,,,5165443,[],CHEMBL1657977,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,8.0
62363,,,5166197,[],CHEMBL1666959,Antimicrobial activity against Citrobacter freundii assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,77.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,%,UO_0000187,,77.0
62364,,,5166198,[],CHEMBL1666956,Antimicrobial activity against Enterobacter aerogenes assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,83.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,Activity,%,UO_0000187,,83.0
62365,,,5166199,[],CHEMBL1666963,Antimicrobial activity against Enterobacter cloacae assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,79.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,79.0
62366,,,5166200,[],CHEMBL1666966,Antimicrobial activity against extended spectrum beta-lactamase-expressing Escherichia coli assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,21.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,21.0
62367,,,5166201,[],CHEMBL1666969,Antimicrobial activity against extended spectrum beta-lactamase-deficient Escherichia coli assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,72.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,72.0
62368,,,5166202,[],CHEMBL1666972,Antimicrobial activity against extended spectrum beta-lactamase-expressing Klebsiella oxytoca assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,41.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,41.0
62369,,,5166203,[],CHEMBL1666975,Antimicrobial activity against extended spectrum beta-lactamase-deficient Klebsiella oxytoca assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,97.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,97.0
62370,,,5166204,[],CHEMBL1666965,Antimicrobial activity against extended spectrum beta-lactamase-expressing Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,43.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,43.0
62371,,,5166205,[],CHEMBL1666980,Antimicrobial activity against extended spectrum beta-lactamase-deficient Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,94.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,94.0
62372,,,5166206,[],CHEMBL1666983,Antimicrobial activity against Proteus mirabilis assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,84.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,84.0
62373,,,5166207,[],CHEMBL1666986,Antimicrobial activity against Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649562,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327185,=,1,0,=,,Activity,%,,73.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,73.0
62374,,,5166287,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.25
62375,,,5166295,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.12
62376,,,5166304,[],CHEMBL1667173,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
62377,,,5166311,[],CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
62378,,,5166319,[],CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62379,,,5166326,[],CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62380,,Not Active,5166333,[],CHEMBL1667172,Antibacterial activity against Listeria monocytogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,Activity,,,,
62381,,,5166340,[],CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,0.25
62382,,,5166347,[],CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,128.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,128.0
62383,,,5166354,[],CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC50,ug ml-1,UO_0000274,,32.0
62384,,,5166361,[],CHEMBL1667171,Antibacterial activity against vancomycin- resistant Enterococcus faecium assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,30.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,30.9
62385,,,5166368,[],CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.25
62386,,,5166375,[],CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,64.0
62387,,,5166382,[],CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62388,,,5166389,[],CHEMBL1667170,Antibacterial activity against vancomycin- resistant Enterococcus faecalis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,58.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,58.5
62389,,,5166396,[],CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.12
62390,,,5166404,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
62391,,,5166411,[],CHEMBL1667174,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
62392,,,5166420,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,,MIC50,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,8.0
62393,,,5166428,[],CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62394,,,5166436,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.12
62395,,,5166443,[],CHEMBL1667175,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,100.0
62396,,,5166452,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.12
62397,,Not Active,5166460,[],CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,MIC90,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,,,,
62398,,,5166468,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
62399,,,5166476,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.06
62400,,,5166484,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,0.06
62401,,,5166492,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC,ug ml-1,UO_0000274,,0.06
62402,,,5166500,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC,ug ml-1,UO_0000274,,0.06
62403,,,5166508,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC,ug ml-1,UO_0000274,,0.06
62404,,,5166518,[],CHEMBL1657977,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,128.0
62405,,,5166528,[],CHEMBL1657978,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
62406,,,5166538,[],CHEMBL1657978,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.125
62407,,,5166548,[],CHEMBL1657978,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62408,,,5166558,[],CHEMBL1657998,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,18.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,18.0
62409,,,5166566,[],CHEMBL1657997,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,81.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,81.0
62410,,,5166574,[],CHEMBL1657996,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,82.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,82.0
62411,,,5166581,[],CHEMBL1657995,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,15.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,15.0
62412,,,5166588,[],CHEMBL1657994,Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.5
62413,,,5166598,[],CHEMBL1657994,Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,ug ml-1,UO_0000274,,16.0
62414,,,5166608,[],CHEMBL1657994,Bactericidal activity against methicillin-resistant Staphylococcus aureus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,ug ml-1,UO_0000274,,512.0
62415,,,5166618,[],CHEMBL1657992,Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.125
62416,,,5166628,[],CHEMBL1657992,Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC50,ug ml-1,UO_0000274,,1.0
62417,,,5166638,[],CHEMBL1657992,Bactericidal activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC90,ug ml-1,UO_0000274,,8.0
62418,,,5166648,[],CHEMBL1657993,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,0.25
62419,,,5166658,[],CHEMBL1657993,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62420,,,5166668,[],CHEMBL1657993,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62421,,,5166678,[],CHEMBL1657991,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,26.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,26.0
62422,,,5166686,[],CHEMBL1657990,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,59.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,59.0
62423,,,5166693,[],CHEMBL1657989,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MBC,ug ml-1,UO_0000274,,0.5
62424,,,5166703,[],CHEMBL1657989,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MBC50,ug ml-1,UO_0000274,,4.0
62425,,,5166713,[],CHEMBL1657989,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,16.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MBC90,ug ml-1,UO_0000274,,16.0
62426,,,5166723,[],CHEMBL1657988,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
62427,,,5166733,[],CHEMBL1657988,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62428,,,5166743,[],CHEMBL1657988,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62429,,,5166753,[],CHEMBL1657987,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,26.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,26.0
62430,,,5166761,[],CHEMBL1657986,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,59.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,59.0
62431,,,5166768,[],CHEMBL1657985,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,ug ml-1,UO_0000274,,0.5
62432,,,5166778,[],CHEMBL1657985,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC50,ug ml-1,UO_0000274,,4.0
62433,,,5166788,[],CHEMBL1657985,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC90,ug ml-1,UO_0000274,,16.0
62434,,,5166798,[],CHEMBL1657984,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.25
62435,,,5166808,[],CHEMBL1657984,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62436,,,5166818,[],CHEMBL1657984,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62437,,,5166828,[],CHEMBL1657983,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,26.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,26.0
62438,,,5166836,[],CHEMBL1657982,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,59.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,59.0
62439,,,5166843,[],CHEMBL1657981,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC,ug ml-1,UO_0000274,,0.5
62440,,,5166853,[],CHEMBL1657981,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC50,ug ml-1,UO_0000274,,4.0
62441,,,5167562,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,8.0
62442,,,5167570,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,4.0
62443,,,5167578,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC50,ug ml-1,UO_0000274,,8.0
62444,,,5167586,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62445,,,5167594,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62446,,,5167602,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC50,ug ml-1,UO_0000274,,0.12
62447,,Not Active,5167610,[],CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,MIC90,,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,,,,
62448,,,5167618,[],CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62449,,,5167626,[],CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62450,,,5167634,[],CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62451,,,5167642,[],CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62452,,,5167650,[],CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62453,,,5167657,[],CHEMBL1667176,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
62454,,,5167665,[],CHEMBL1667177,Antibacterial activity against Staphylococcus haemolyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,37.6,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,37.6
62455,,,5167673,[],CHEMBL1667178,Antibacterial activity against Staphylococcus hominis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,30.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,30.0
62456,,,5167681,[],CHEMBL1667179,Antibacterial activity against Staphylococcus lugdunensis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,66.7,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,,Activity,%,UO_0000187,,66.7
62457,,,5167689,[],CHEMBL1667180,Antibacterial activity against Staphylococcus saprophyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,,Activity,%,UO_0000187,,100.0
62458,,,5167697,[],CHEMBL1667181,Antibacterial activity against Staphylococcus warneri assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,74.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,,Activity,%,UO_0000187,,74.0
62459,,,5167705,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
62460,,,5167713,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
62461,,,5167721,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC,ug ml-1,UO_0000274,,0.12
62462,,,5167729,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
62463,,,5167737,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62464,,,5167745,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
62465,,,5167753,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62466,,,5167761,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.5
62467,,,5167769,[],CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62468,,,5167777,[],CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
62469,,,5167785,[],CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62470,,,5167793,[],CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
62471,,Not Active,5167801,[],CHEMBL1667182,Antibacterial activity against Streptococcus agalactiae assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,,,,
62472,,Not Active,5167809,[],CHEMBL1667183,Antibacterial activity against Lancefield Streptococcus sp. 'group C' assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
62473,,Not Active,5167817,[],CHEMBL1667184,Antibacterial activity against Lancefield Streptococcus sp. group F assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,,Activity,,,,
62474,,Not Active,5167825,[],CHEMBL1667185,Antibacterial activity against Lancefield Streptococcus sp. 'group G' assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
62475,,,5167833,[],CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
62476,,,5167840,[],CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
62477,,,5167847,[],CHEMBL1667186,Antibacterial activity against levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,100.0
62478,,,5167854,[],CHEMBL1667187,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
62479,,,5167861,[],CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62480,,,5167868,[],CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,16.0
62481,,,5167875,[],CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62482,,,5167882,[],CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62483,,,5167890,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.25
62484,,,5167898,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.12
62485,,,5167908,[],CHEMBL1657981,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,16.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC90,ug ml-1,UO_0000274,,16.0
62486,,,5167918,[],CHEMBL1657980,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC,ug ml-1,UO_0000274,,0.25
62487,,,5167928,[],CHEMBL1657980,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62488,,,5167938,[],CHEMBL1657980,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62489,,,5167947,[],CHEMBL1657979,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,15.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,15.0
62490,,,5167953,[],CHEMBL1658118,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,59.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,59.0
62491,,,5167960,[],CHEMBL1658119,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC,ug ml-1,UO_0000274,,0.5
62492,,,5167970,[],CHEMBL1658119,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC50,ug ml-1,UO_0000274,,4.0
62493,,,5167980,[],CHEMBL1658119,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,16.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC90,ug ml-1,UO_0000274,,16.0
62494,,,5167990,[],CHEMBL1658120,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC,ug ml-1,UO_0000274,,0.25
62495,,,5168000,[],CHEMBL1658120,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62496,,,5168010,[],CHEMBL1658120,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62497,,,5168019,[],CHEMBL1658121,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,15.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,15.0
62498,,,5168025,[],CHEMBL1658122,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,59.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,59.0
62499,,,5168032,[],CHEMBL1658123,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC,ug ml-1,UO_0000274,,0.5
62500,,,5168042,[],CHEMBL1658123,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC50,ug ml-1,UO_0000274,,4.0
62501,,,5168052,[],CHEMBL1658123,Bactericidal activity against methicillin-resistant coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,16.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC90,ug ml-1,UO_0000274,,16.0
62502,,,5168062,[],CHEMBL1658124,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,0.25
62503,,,5168072,[],CHEMBL1658124,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62504,,,5168082,[],CHEMBL1658124,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62505,,,5168092,[],CHEMBL1658125,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,96.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,96.0
62506,,,5168100,[],CHEMBL1658748,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,4.0
62507,,,5168107,[],CHEMBL1658749,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MBC,ug ml-1,UO_0000274,,0.5
62508,,,5168117,[],CHEMBL1658749,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,1.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MBC50,ug ml-1,UO_0000274,,1.0
62509,,,5168127,[],CHEMBL1658749,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus hominis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MBC90,ug ml-1,UO_0000274,,4.0
62510,,,5168137,[],CHEMBL1658750,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
62511,,,5168147,[],CHEMBL1658750,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62512,,,5168157,[],CHEMBL1658750,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62513,,,5168167,[],CHEMBL1658751,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,96.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,96.0
62514,,,5168175,[],CHEMBL1658752,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,4.0
62515,,,5168182,[],CHEMBL1658753,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,ug ml-1,UO_0000274,,0.5
62516,,,5168192,[],CHEMBL1658753,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC50,ug ml-1,UO_0000274,,1.0
62517,,,5168202,[],CHEMBL1658753,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC90,ug ml-1,UO_0000274,,4.0
62518,,,5168212,[],CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,0.25
62519,,,5168222,[],CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62520,,,5168232,[],CHEMBL1658754,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62521,,,5168989,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,0.12
62522,,,5168997,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC,ug ml-1,UO_0000274,,0.12
62523,,,5169005,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC,ug ml-1,UO_0000274,,0.12
62524,,,5169013,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC,ug ml-1,UO_0000274,,0.12
62525,,,5169021,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC,ug ml-1,UO_0000274,,0.12
62526,,,5169029,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC,ug ml-1,UO_0000274,,0.12
62527,,,5169037,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC,ug ml-1,UO_0000274,,0.12
62528,,,5169045,[],CHEMBL1667188,Antibacterial activity against Streptococcus pyogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.5
62529,,Not Active,5169053,[],CHEMBL1667189,Antibacterial activity against Streptococcus anginosus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
62530,,Not Active,5169061,[],CHEMBL1667190,Antibacterial activity against Streptococcus bovis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,Activity,,,,
62531,,Not Active,5169069,[],CHEMBL1667191,Antibacterial activity against Streptococcus constellatus assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,Activity,,,,
62532,,Not Active,5169077,[],CHEMBL1667192,Antibacterial activity against Streptococcus intermedius assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,Activity,,,,
62533,,Not Active,5169085,[],CHEMBL1667193,Antibacterial activity against Streptococcus mitis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,Activity,,,,
62534,,Not Active,5169093,[],CHEMBL1667194,Antibacterial activity against Streptococcus oralis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,Activity,,,,
62535,,Not Active,5169101,[],CHEMBL1667195,Antibacterial activity against Streptococcus salivarius assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,Activity,,,,
62536,,Not Active,5169109,[],CHEMBL1667196,Antibacterial activity against Streptococcus sanguinis assessed as percent susceptible isolates by CLSI M100-S18 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,Activity,,,,
62537,,,5169118,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62538,,,5169126,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,1.0
62539,,,5169133,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62540,,,5169141,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62541,,,5169149,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62542,,,5169157,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62543,,,5169165,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62544,,,5169173,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62545,,,5169181,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62546,,,5169190,[],CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62547,,,5169198,[],CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,1.0
62548,,,5169205,[],CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62549,,,5169213,[],CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62550,,,5169221,[],CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62551,,,5169229,[],CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62552,,,5169237,[],CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62553,,,5169245,[],CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62554,,,5169253,[],CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62555,,,5169260,[],CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.03
62556,,,5169267,[],CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC,ug ml-1,UO_0000274,,0.015
62557,,,5169274,[],CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC,ug ml-1,UO_0000274,,0.015
62558,,,5169281,[],CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.015
62559,,,5169288,[],CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,8.0
62560,,,5169295,[],CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62561,,,5169302,[],CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC50,ug ml-1,UO_0000274,,0.12
62562,,,5169309,[],CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC50,ug ml-1,UO_0000274,,0.06
62563,,,5169316,[],CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,64.0
62564,,,5169323,[],CHEMBL1658755,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,96.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,96.0
62565,,,5169331,[],CHEMBL1658756,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,4.0
62566,,,5169338,[],CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC,ug ml-1,UO_0000274,,0.5
62567,,,5169348,[],CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC50,ug ml-1,UO_0000274,,1.0
62568,,,5169358,[],CHEMBL1658757,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,4.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MBC90,ug ml-1,UO_0000274,,4.0
62569,,,5169368,[],CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC,ug ml-1,UO_0000274,,0.25
62570,,,5169378,[],CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62571,,,5169388,[],CHEMBL1658758,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62572,,,5169398,[],CHEMBL1658759,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,96.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,96.0
62573,,,5169406,[],CHEMBL1658760,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,4.0
62574,,,5169412,[],CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC,ug ml-1,UO_0000274,,0.5
62575,,,5169422,[],CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,1.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC50,ug ml-1,UO_0000274,,1.0
62576,,,5169432,[],CHEMBL1658761,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus simulans after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,4.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,MBC90,ug ml-1,UO_0000274,,4.0
62577,,,5169442,[],CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC,ug ml-1,UO_0000274,,0.25
62578,,,5169452,[],CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62579,,,5169462,[],CHEMBL1658762,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62580,,,5169472,[],CHEMBL1658763,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as susceptible isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,96.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,96.0
62581,,,5169481,[],CHEMBL1658921,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,4.0
62582,,,5169496,[],CHEMBL1658933,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
62583,,,5169501,[],CHEMBL1658934,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,4.0
62584,,,5169506,[],CHEMBL1658935,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,15.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,15.0
62585,,,5169511,[],CHEMBL1658936,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,15.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,15.0
62586,,,5169516,[],CHEMBL1658937,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,15.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,15.0
62587,,,5169521,[],CHEMBL1658938,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,15.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,15.0
62588,,,5169526,[],CHEMBL1658939,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,0.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,0.0
62589,,,5169531,[],CHEMBL1658940,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus epidermidis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,0.0
62590,,,5169536,[],CHEMBL1658941,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus haemolyticus assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,0.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,Activity,%,UO_0000187,,0.0
62591,,,5169541,[],CHEMBL1658942,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus simulans assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,0.0,CHEMBL612425,Staphylococcus simulans,Staphylococcus simulans,1286.0,,,Activity,%,UO_0000187,,0.0
62592,,,5169546,[],CHEMBL1658943,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,0.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,Activity,%,UO_0000187,,0.0
62593,,,5169551,[],CHEMBL1658944,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus hominis assessed as intermediate resistant isolates after 24 hrs by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322364,=,1,0,=,,Activity,%,,15.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,Activity,%,UO_0000187,,15.0
62594,,,5169557,[],CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC,ug ml-1,UO_0000274,,0.5
62595,,,5169567,[],CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC50,ug ml-1,,1.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC50,ug ml-1,UO_0000274,,1.0
62596,,,5169577,[],CHEMBL1658922,Bactericidal activity against methicillin-susceptible coagulase-negative Staphylococcus sciuri after 24 hrs by plate counting method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649231,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322364,=,1,0,=,,MBC90,ug ml-1,,4.0,CHEMBL613150,Mammaliicoccus sciuri,Mammaliicoccus sciuri,1296.0,,,MBC90,ug ml-1,UO_0000274,,4.0
62597,,,5170369,[],CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62598,,,5170376,[],CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,MIC90,ug ml-1,UO_0000274,,4.0
62599,,,5170383,[],CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC90,ug ml-1,UO_0000274,,2.0
62600,,,5170390,[],CHEMBL1667197,Antibacterial activity against Acinetobacter baumannii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,37.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,37.7
62601,,,5170397,[],CHEMBL1667198,Antibacterial activity against Acinetobacter calcoaceticus assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,66.7,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,,Activity,%,UO_0000187,,66.7
62602,,,5170404,[],CHEMBL1667199,Antibacterial activity against Acinetobacter lwoffii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,86.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,,Activity,%,UO_0000187,,86.0
62603,,,5170411,[],CHEMBL1667200,Antibacterial activity against Citrobacter freundii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,90.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Activity,%,UO_0000187,,90.0
62604,,,5170419,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC,ug ml-1,UO_0000274,,0.015
62605,,,5170426,[],CHEMBL1667201,Antibacterial activity against Citrobacter koseri assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,99.0,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,Activity,%,UO_0000187,,99.0
62606,,,5170435,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC50,ug ml-1,UO_0000274,,0.03
62607,,,5170443,[],CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,,MIC90,ug ml-1,UO_0000274,,0.12
62608,,,5170451,[],CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC,ug ml-1,UO_0000274,,0.03
62609,,,5170458,[],CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.008
62610,,,5170465,[],CHEMBL1667202,Antibacterial activity against Enterobacter aerogenes assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,80.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,Activity,%,UO_0000187,,80.0
62611,,,5170472,[],CHEMBL1667203,Antibacterial activity against Enterobacter cloacae assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,92.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Activity,%,UO_0000187,,92.0
62612,,,5170479,[],CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC50,ug ml-1,UO_0000274,,0.06
62613,,,5170486,[],CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC50,ug ml-1,UO_0000274,,0.03
62614,,,5170493,[],CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62615,,,5170500,[],CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC90,ug ml-1,UO_0000274,,0.25
62616,,,5170507,[],CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.008
62617,,,5170514,[],CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.0
62618,,,5170521,[],CHEMBL1667204,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,0,=,,Activity,ug ml-1,,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,ug ml-1,UO_0000274,,100.0
62619,,,5170528,[],CHEMBL1667205,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000181,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,0,=,,Activity,ug ml-1,,27.3,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Activity,ug ml-1,UO_0000274,,27.3
62620,,,5170535,[],CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,0.015
62621,,,5170542,[],CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,8.0
62622,,,5170549,[],CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,0.015
62623,,,5170556,[],CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62624,,,5170564,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.015
62625,,,5170571,[],CHEMBL1667206,Antibacterial activity against Klebsiella oxytoca assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,90.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Activity,%,UO_0000187,,90.0
62626,,,5170580,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC50,ug ml-1,UO_0000274,,0.03
62627,,,5170588,[],CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62628,,,5170595,[],CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,<=,1,1,<=,,MIC,ug.mL-1,,0.004,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.004
62629,,,5170602,[],CHEMBL1667207,Antibacterial activity against Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,91.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,%,UO_0000187,,91.0
62630,,,5170609,[],CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC50,ug ml-1,UO_0000274,,0.06
62631,,,5170616,[],CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC90,ug ml-1,UO_0000274,,2.0
62632,,,5170623,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC,ug ml-1,UO_0000274,,0.015
62633,,,5170630,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.008
62634,,Not Active,5170638,[],CHEMBL1667208,Antibacterial activity against Legionella pneumophila assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1327196,,1,0,,,Activity,,,,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,Activity,,,,
62635,,,5170645,[],CHEMBL1667209,Antibacterial activity against Moraxella catarrhalis assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Activity,%,UO_0000187,,100.0
62636,,,5170653,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC50,ug ml-1,UO_0000274,,0.03
62637,,,5170660,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC50,ug ml-1,UO_0000274,,0.015
62638,,,5170668,[],CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.03,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,,MIC90,ug ml-1,UO_0000274,,0.03
62639,,,5170675,[],CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC90,ug ml-1,UO_0000274,,0.015
62640,,,5170684,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.015
62641,,,5170691,[],CHEMBL1667210,Antibacterial activity against Morganella morganii assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,76.5,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,Activity,%,UO_0000187,,76.5
62642,,,5170700,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC50,ug ml-1,UO_0000274,,0.06
62643,,,5171750,[],CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62644,,,5171758,[],CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,<=,1,1,<=,,MIC,ug.mL-1,,0.004,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC,ug ml-1,UO_0000274,,0.004
62645,,,5171764,[],CHEMBL1667338,Antibacterial activity against Neisseria meningitidis assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,Activity,%,UO_0000187,,100.0
62646,,,5171770,[],CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC50,ug ml-1,UO_0000274,,0.008
62647,,,5171776,[],CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.015,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC90,ug ml-1,UO_0000274,,0.015
62648,,,5171780,[],CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.015
62649,,,5171787,[],CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.015
62650,,,5171794,[],CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.06
62651,,,5171801,[],CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
62652,,,5171808,[],CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.03
62653,,,5171815,[],CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,0.12
62654,,,5171822,[],CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC,ug ml-1,UO_0000274,,4.0
62655,,,5171829,[],CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC50,ug ml-1,UO_0000274,,0.03
62656,,,5171836,[],CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC50,ug ml-1,UO_0000274,,0.03
62657,,,5171843,[],CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62658,,,5171850,[],CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC50,ug ml-1,UO_0000274,,16.0
62659,,,5171857,[],CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC50,ug ml-1,UO_0000274,,0.12
62660,,,5171864,[],CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62661,,,5171871,[],CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC50,ug ml-1,UO_0000274,,8.0
62662,,,5171878,[],CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC90,ug ml-1,UO_0000274,,8.0
62663,,,5171885,[],CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC90,ug ml-1,UO_0000274,,0.06
62664,,,5171892,[],CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62665,,,5171899,[],CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,ug ml-1,UO_0000274,,64.0
62666,,,5171906,[],CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62667,,,5171913,[],CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,2.0
62668,,,5171920,[],CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327196,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,MIC90,ug ml-1,UO_0000274,,32.0
62669,,,5171927,[],CHEMBL1667339,Antibacterial activity against Proteus mirabilis assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,76.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Activity,%,UO_0000187,,76.0
62670,,,5171934,[],CHEMBL1667340,Antibacterial activity against Proteus vulgaris assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,Activity,%,UO_0000187,,100.0
62671,,,5171941,[],CHEMBL1667341,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,96.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,96.2
62672,,,5171948,[],CHEMBL1667342,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Activity,%,UO_0000187,,1.0
62673,,,5171955,[],CHEMBL1667343,Antibacterial activity against levofloxacin susceptible Serratia marcescens assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Activity,%,UO_0000187,,100.0
62674,,,5171962,[],CHEMBL1667344,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,100.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,100.0
62675,,,5171969,[],CHEMBL1667346,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia assessed as assessed as percent susceptible isolates by CLSI M7-A7 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327196,=,1,0,=,,Activity,%,,0.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,,Activity,%,UO_0000187,,0.0
62676,,,5172692,[],CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,>,1,1,>,,MIC,ug.mL-1,,0.094,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.094
62677,,,5172723,[],CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,32.0
62678,,,5172725,[],CHEMBL1654759,Antimicrobial activity against Desulfovibrio fairfieldensis by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,32.0
62679,,,5172738,[],CHEMBL1654758,Antimicrobial activity against Desulfovibrio sp. by Etest method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,=,1,1,=,,MIC50,ug.mL-1,,0.75,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.75
62680,,,5172767,[],CHEMBL1654762,Antimicrobial activity against Desulfovibrio piger by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,=,1,1,=,,MIC,ug.mL-1,,0.095,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.095
62681,,,5172776,[],CHEMBL1654761,Antimicrobial activity against Desulfovibrio desulfuricans MB by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.25
62682,,,5173169,[],CHEMBL1667374,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321812,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,1.0
62683,,,5173170,[],CHEMBL1667375,Antimicrobial activity against Pseudomonas aeruginosa isolate NH57388A by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321812,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,2.0
62684,,,5173175,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '60.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '60.0'}]",CHEMBL1667376,"Cmax in mouse at 60 mg/kg, administered as single dose through aerosol",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,Cmax,mg Kg-1,,6.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,mg Kg-1,UO_0000308,,6.2
62685,,,5173176,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '60.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '60.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'INTRAPERITONEAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'INTRAPERITONEAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1667378,"Cmax in mouse at 60 mg/kg, ip administered as single dose",A,,,BAO_0002119,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,Cmax,mg Kg-1,,18.6,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,Cmax,mg Kg-1,UO_0000308,,18.6
62686,,,5173177,[],CHEMBL1667377,"Normalised AUC in mouse at 60 mg/kg, administered as single dose through aerosol",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,AUC,mg.hr/kg,,4.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,mg.hr/kg,,,4.1
62687,,,5173178,[],CHEMBL1667379,"Normalised AUC in mouse at 60 mg/kg, ip administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,AUC,mg.hr/kg,,4.1,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,AUC,mg.hr/kg,,,4.1
62688,,,5173179,[],CHEMBL1667380,"Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 infected in Swiss neutropenic mouse assessed as reduction in lung bacterial load at 125 mg/kg, ip BID administered 24 hrs post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,log10cfu,,,3.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,3.5
62689,,,5173180,[],CHEMBL1667381,"Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 infected in Swiss neutropenic mouse assessed as reduction in lung bacterial load at 63 mg/kg, ip BID administered 24 hrs post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,log10cfu,,,2.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,2.7
62690,,,5173181,[],CHEMBL1667382,"Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 infected in Swiss neutropenic mouse assessed as reduction in lung bacterial load at 32 mg/kg, ip BID administered 24 hrs post infection",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,log10cfu,,,0.65,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,0.65
62691,,,5173188,[],CHEMBL1667383,"Antimicrobial activity against Pseudomonas aeruginosa NH57388A infected in Swiss neutropenic mouse assessed as lung bacterial load at 60 mg/kg, ip BID administered 24 hrs post infection (Rvb = 8.89 logCFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,log10cfu,,,4.93,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,4.93
62692,,,5173189,[],CHEMBL1667384,"Antimicrobial activity against Pseudomonas aeruginosa NH57388A infected in Swiss neutropenic mouse assessed as lung bacterial load at 30 mg/kg, ip BID administered 24 hrs post infection (Rvb = 8.89 logCFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,log10cfu,,,5.73,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,5.73
62693,,,5173190,[],CHEMBL1667385,"Antimicrobial activity against Pseudomonas aeruginosa NH57388A infected in Swiss neutropenic mouse assessed as lung bacterial load at 15 mg/kg, ip BID administered 24 hrs post infection (Rvb = 8.89 logCFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649568,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1321812,=,1,0,=,,log10cfu,,,7.83,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,log10cfu,,,,7.83
62694,,,5173802,[],CHEMBL1654760,Antimicrobial activity against Desulfovibrio desulfuricans Essex 6 by Etest method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649294,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323327,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.25
62695,,,5176037,[],CHEMBL1666916,Antimicrobial activity against SCCmec type IV vancomycin-intermediate Staphylococcus aureus isolate 06b41 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
62696,,,5176183,[],CHEMBL1666911,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b4k6307 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,4.0
62697,,,5176184,[],CHEMBL1666920,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 15b52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,4.0
62698,,,5176186,[],CHEMBL1665469,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy32 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
62699,,,5176187,[],CHEMBL1665531,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate sh06024 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
62700,,,5176189,[],CHEMBL1666919,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 07b63 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
62701,,,5176190,[],CHEMBL1666921,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate zj07028 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
62702,,,5176191,[],CHEMBL1666923,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate xa07029 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
62703,,,5176197,[],CHEMBL1665470,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy39 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
62704,,,5176198,[],CHEMBL1665530,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 5zjsau3 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
62705,,,5176199,[],CHEMBL1666908,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k2345 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
62706,,,5176200,[],CHEMBL1666909,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b2k3421 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
62707,,,5176202,[],CHEMBL1666912,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3529 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
62708,,,5176203,[],CHEMBL1666913,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3578 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
62709,,,5176205,[],CHEMBL1666914,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k1642 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
62710,,,5176216,[],CHEMBL1666905,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 6zjsau7 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62711,,,5176217,[],CHEMBL1666906,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate bd4768 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62712,,,5176218,[],CHEMBL1666907,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate b2k4781 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62713,,,5176219,[],CHEMBL1666910,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k5923 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62714,,,5176221,[],CHEMBL1666917,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 13b16 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62715,,,5176222,[],CHEMBL1666918,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 11b091 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62716,,,5176224,[],CHEMBL1666922,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate sh07043 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62717,,,5176226,[],CHEMBL1666925,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gs07022 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
62718,,,5176234,[],CHEMBL1665532,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06040 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
62719,,,5176236,[],CHEMBL1665533,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06051 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
62720,,,5176245,[],CHEMBL1666915,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k7974 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
62721,,,5176249,[],CHEMBL1666924,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz07030 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321871,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
62722,,,5177908,[],CHEMBL1659089,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
62723,,,5177915,[],CHEMBL1659090,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 144 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
62724,,,5177927,[],CHEMBL1659092,Antibacterial activity against community-acquired methicillin-resistant Staphylococcus aureus 147 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
62725,,,5177934,[],CHEMBL1659093,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus 56 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
62726,,,5177941,[],CHEMBL1659094,Antibacterial activity against hospital-acquired methicillin-resistant Staphylococcus aureus 152 by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649261,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322811,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
62727,,,5179126,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,,MIC,ug.mL-1,,0.012,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.012
62728,,,5179135,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62729,,,5179144,[],CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62730,,,5179153,[],CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC,ug ml-1,UO_0000274,,0.1
62731,,,5179160,[],CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC50,ug ml-1,UO_0000274,,0.25
62732,,,5179167,[],CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322825,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62733,,,5179195,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62734,,,5179206,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC50,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug/L,UO_0000274,,1.0
62735,,,5179217,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC90,ug.mL-1,,0.002,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug/L,UO_0000274,,2.0
62736,,,5179228,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.0005,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.5
62737,,,5179239,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0003035,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC50,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug/L,UO_0000274,,1.0
62738,,,5179250,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC90,ug.mL-1,,0.004,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug/L,UO_0000274,,4.0
62739,,,5179261,[],CHEMBL1660034,Antibacterial activity against Mycoplasma genitalium G37 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,1.0
62740,,,5179272,[],CHEMBL1660035,Antibacterial activity against Mycoplasma genitalium M30 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,1.0
62741,,,5179283,[],CHEMBL1660036,Antibacterial activity against Mycoplasma genitalium R32 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,1.0
62742,,,5179294,[],CHEMBL1660037,Antibacterial activity against Mycoplasma genitalium TW10-5G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,1.0
62743,,,5179305,[],CHEMBL1660038,Antibacterial activity against Mycoplasma genitalium TW10-6G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,1.0
62744,,,5179316,[],CHEMBL1660039,Antibacterial activity against Mycoplasma genitalium TW48-5G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,1.0
62745,,,5179327,[],CHEMBL1660040,Antibacterial activity against Mycoplasma genitalium UTMB-10G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.001,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,1.0
62746,,,5179338,[],CHEMBL1660041,Antibacterial activity against Mycoplasma genitalium M2282 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62747,,,5179349,[],CHEMBL1660042,Antibacterial activity against Mycoplasma genitalium M2300 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62748,,,5179360,[],CHEMBL1660043,Antibacterial activity against Mycoplasma genitalium M2321 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62749,,,5179371,[],CHEMBL1660044,Antibacterial activity against Mycoplasma genitalium M2341 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62750,,,5179382,[],CHEMBL1660045,Antibacterial activity against Mycoplasma genitalium M6257 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62751,,,5179393,[],CHEMBL1660046,Antibacterial activity against Mycoplasma genitalium M6280 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62752,,,5179404,[],CHEMBL1660047,Antibacterial activity against Mycoplasma genitalium M6285 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62753,,,5179415,[],CHEMBL1660048,Antibacterial activity against Mycoplasma genitalium M6286 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62754,,,5179426,[],CHEMBL1660173,Antibacterial activity against Mycoplasma genitalium M6328 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62755,,,5180480,[],CHEMBL1660174,Antibacterial activity against Mycoplasma genitalium M6090 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62756,,,5180491,[],CHEMBL1660175,Antibacterial activity against Mycoplasma genitalium M6151 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62757,,,5180502,[],CHEMBL1660176,Antibacterial activity against Mycoplasma genitalium M6282 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62758,,,5180513,[],CHEMBL1660177,Antibacterial activity against Mycoplasma genitalium M6283 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62759,,,5180524,[],CHEMBL1660178,Antibacterial activity against Mycoplasma genitalium M6284 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62760,,,5180535,[],CHEMBL1660179,Antibacterial activity against Mycoplasma genitalium M6287 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322839,=,1,1,=,,MIC,ug.mL-1,,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.125
62761,,,5181930,[],CHEMBL1660391,Antimicrobial activity against Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62762,,,5181931,[],CHEMBL1660390,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62763,,,5181932,[],CHEMBL1660389,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
62764,,,5181933,[],CHEMBL1660389,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62765,,,5182026,[],CHEMBL1660388,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
62766,,,5182034,[],CHEMBL1660387,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
62767,,,5182042,[],CHEMBL1660386,Antimicrobial activity against Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.03
62768,,,5182050,[],CHEMBL1660385,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.03
62769,,,5182058,[],CHEMBL1660384,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.03
62770,,,5182066,[],CHEMBL1660383,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.03
62771,,,5182074,[],CHEMBL1660382,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,4.0
62772,,,5182080,[],CHEMBL1660381,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.25
62773,,,5182086,[],CHEMBL1660380,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.25
62774,,,5182092,[],CHEMBL1660379,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.5
62775,,,5182098,[],CHEMBL1660378,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
62776,,,5182104,[],CHEMBL1660377,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.06
62777,,,5182110,[],CHEMBL1660376,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.12
62778,,,5182116,[],CHEMBL1660375,Antimicrobial activity against Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
62779,,,5182122,[],CHEMBL1660374,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
62780,,,5182128,[],CHEMBL1660373,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.25
62781,,,5182134,[],CHEMBL1660372,Antimicrobial activity against Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
62782,,,5182140,[],CHEMBL1660371,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.03
62783,,,5182146,[],CHEMBL1660370,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.25
62784,,,5182152,[],CHEMBL1660369,Antimicrobial activity against Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,ug ml-1,UO_0000274,,0.03
62785,,,5182158,[],CHEMBL1660368,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,ug ml-1,UO_0000274,,0.03
62786,,,5182164,[],CHEMBL1660367,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC,ug ml-1,UO_0000274,,0.25
62787,,,5182173,[],CHEMBL1652892,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
62788,,,5182183,[],CHEMBL1652894,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
62789,,,5182193,[],CHEMBL1652896,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
62790,,,5183335,[],CHEMBL1660388,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62791,,,5183343,[],CHEMBL1660387,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62792,,,5183351,[],CHEMBL1660386,Antimicrobial activity against Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62793,,,5183359,[],CHEMBL1660385,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62794,,,5183367,[],CHEMBL1660384,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62795,,,5183375,[],CHEMBL1660383,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62796,,,5183383,[],CHEMBL1660382,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC90,ug.mL-1,,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62797,,,5183389,[],CHEMBL1660381,Antimicrobial activity against Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62798,,,5183395,[],CHEMBL1660380,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62799,,,5183401,[],CHEMBL1660379,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62800,,,5183407,[],CHEMBL1660378,Antimicrobial activity against Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62801,,,5183413,[],CHEMBL1660377,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62802,,,5183419,[],CHEMBL1660376,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62803,,,5183420,[],CHEMBL1660391,Antimicrobial activity against Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.03
62804,,,5183421,[],CHEMBL1660390,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>=,1,1,>=,,MIC,ug.mL-1,,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.03
62805,,,5183426,[],CHEMBL1652900,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,94.1,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,94.1
62806,,,5183431,[],CHEMBL1652901,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,100.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,100.0
62807,,,5183435,[],CHEMBL1652902,Antimicrobial activity against Streptococcus Group F clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,98.8,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,98.8
62808,,,5183440,[],CHEMBL1652903,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,94.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,94.1
62809,,,5183445,[],CHEMBL1652904,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,100.0
62810,,,5183449,[],CHEMBL1652905,Antimicrobial activity against Streptococcus Group G clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,98.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,98.8
62811,,,5183454,[],CHEMBL1652906,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,94.1,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,94.1
62812,,,5183459,[],CHEMBL1652907,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,100.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,100.0
62813,,,5183463,[],CHEMBL1652908,Antimicrobial activity against Streptococcus Group C clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,98.8,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,98.8
62814,,,5183468,[],CHEMBL1652909,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,99.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,99.2
62815,,,5183473,[],CHEMBL1652910,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,100.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,100.0
62816,,,5183478,[],CHEMBL1652911,Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,99.9,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,99.9
62817,,,5183483,[],CHEMBL1652912,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,95.9,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,95.9
62818,,,5183488,[],CHEMBL1652913,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,98.6,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,98.6
62819,,,5183493,[],CHEMBL1652914,Antimicrobial activity against Streptococcus agalactiae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,97.8,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,97.8
62820,,,5183500,[],CHEMBL1652915,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,0.0
62821,,,5183507,[],CHEMBL1652916,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,0.2
62822,,,5183514,[],CHEMBL1653016,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,0.2
62823,,,5183521,[],CHEMBL1653017,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,28.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,28.3
62824,,,5183528,[],CHEMBL1653018,Antimicrobial activity against Enterococcus faecium clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,12.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,12.2
62825,,,5183535,[],CHEMBL1653019,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,0.0
62826,,,5183542,[],CHEMBL1653020,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,0.0
62827,,,5183549,[],CHEMBL1653021,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,0.0
62828,,,5183556,[],CHEMBL1653022,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,64.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,64.4
62829,,,5183563,[],CHEMBL1653023,Antimicrobial activity against Enterococcus faecalis clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,61.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,61.2
62830,,,5183590,[],CHEMBL1653036,Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,99.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.1
62831,,,5183870,[],CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323829,=,1,1,=,,MIC,ug.mL-1,,0.0313,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.0313
62832,,,5183879,[],CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323829,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC50,ug ml-1,UO_0000274,,4.0
62833,,,5183888,[],CHEMBL1664557,Antimicrobial activity against Acinetobacter baumannii by broth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323829,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC90,ug ml-1,UO_0000274,,16.0
62834,,,5183897,[],CHEMBL1664555,Antimicrobial activity against Acinetobacter baumannii assessed as susceptible isolate by broth dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1323829,=,1,0,=,,Activity,%,,38.6,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,38.6
62835,,,5183906,[],CHEMBL1664553,Antimicrobial activity against Acinetobacter baumannii assessed as resistant isolate by broth dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649327,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1323829,=,1,0,=,,Activity,%,,32.8,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Activity,%,UO_0000187,,32.8
62836,,,5184170,[],CHEMBL1653421,Antibacterial activity against Streptococcus pneumoniae by CLSI M100-S17 method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327134,=,1,1,=,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
62837,,,5184171,[],CHEMBL1653421,Antibacterial activity against Streptococcus pneumoniae by CLSI M100-S17 method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327134,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62838,,,5184172,[],CHEMBL1653421,Antibacterial activity against Streptococcus pneumoniae by CLSI M100-S17 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327134,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
62839,,,5184173,[],CHEMBL1653422,Antibacterial activity against Streptococcus pneumoniae assessed as susceptible isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327134,=,1,0,=,,Activity,%,,99.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.4
62840,,,5184174,[],CHEMBL1653423,Antibacterial activity against Streptococcus pneumoniae assessed as intermediate isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327134,=,1,0,=,,Activity,%,,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.0
62841,,,5184175,[],CHEMBL1653424,Antibacterial activity against Streptococcus pneumoniae assessed as resistant isolates by CLSI M100-S17 method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649552,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1327134,=,1,0,=,,Activity,%,,0.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.6
62842,,,5184651,[],CHEMBL1653038,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,99.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.5
62843,,,5184660,[],CHEMBL1653040,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,97.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,97.7
62844,,,5184669,[],CHEMBL1653042,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates assessed as percent susceptible isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,99.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,99.3
62845,,,5184674,[],CHEMBL1653035,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,0.0
62846,,,5184678,[],CHEMBL1653034,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,0.0
62847,,,5184682,[],CHEMBL1653033,Antimicrobial activity against Streptococcus Group F clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,Activity,%,UO_0000187,,0.0
62848,,,5184686,[],CHEMBL1653044,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
62849,,,5184690,[],CHEMBL1653045,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
62850,,,5184694,[],CHEMBL1653046,Antimicrobial activity against Streptococcus Group G clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
62851,,,5184698,[],CHEMBL1653047,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
62852,,,5184702,[],CHEMBL1653818,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
62853,,,5184706,[],CHEMBL1653819,Antimicrobial activity against Streptococcus Group C clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,0.0
62854,,,5184710,[],CHEMBL1653820,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.8
62855,,,5184714,[],CHEMBL1653821,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.0
62856,,,5184718,[],CHEMBL1653822,Antimicrobial activity against Streptococcus pyogenes clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.1,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Activity,%,UO_0000187,,0.1
62857,,,5184723,[],CHEMBL1653823,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,4.1,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,4.1
62858,,,5184728,[],CHEMBL1653824,Antimicrobial activity against erythromycin-susceptible Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,1.4,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,1.4
62859,,,5184733,[],CHEMBL1653825,Antimicrobial activity against Streptococcus agalactiae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,2.2,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,Activity,%,UO_0000187,,2.2
62860,,,5184739,[],CHEMBL1653826,Antimicrobial activity against Enterococcus faecium expressing VanB gene clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,100.0
62861,,,5184745,[],CHEMBL1653827,Antimicrobial activity against Enterococcus faecium expressing VanA gene clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,99.8,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,99.8
62862,,,5184751,[],CHEMBL1653828,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,99.8,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,99.8
62863,,,5184757,[],CHEMBL1653829,Antimicrobial activity against vancomycin-susceptible Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,66.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,66.0
62864,,,5184763,[],CHEMBL1653830,Antimicrobial activity against Enterococcus faecium clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,85.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,Activity,%,UO_0000187,,85.3
62865,,,5184769,[],CHEMBL1653831,Antimicrobial activity against Enterococcus faecalis expressing VanB gene clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
62866,,,5184775,[],CHEMBL1653832,Antimicrobial activity against Enterococcus faecalis expressing VanA gene clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
62867,,,5184781,[],CHEMBL1653833,Antimicrobial activity against vancomycin-nonsusceptible Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,100.0
62868,,,5184787,[],CHEMBL1653834,Antimicrobial activity against vancomycin-susceptible Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,35.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,35.2
62869,,,5184793,[],CHEMBL1653835,Antimicrobial activity against Enterococcus faecalis clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,38.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,%,UO_0000187,,38.4
62870,,,5184837,[],CHEMBL1653845,Antimicrobial activity against Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.9
62871,,,5184845,[],CHEMBL1653847,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.5
62872,,,5184853,[],CHEMBL1653849,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,2.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,2.3
62873,,,5184861,[],CHEMBL1653951,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates assessed as resistant isolates by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1322874,=,1,0,=,,Activity,%,,0.7,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,0.7
62874,,,5184918,[],CHEMBL1660375,Antimicrobial activity against Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
62875,,,5184919,[],CHEMBL1660372,Antimicrobial activity against Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
62876,,,5184920,[],CHEMBL1660369,Antimicrobial activity against Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62877,,,5184930,[],CHEMBL1660374,Antimicrobial activity against erythromycin-susceptible Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
62878,,,5184931,[],CHEMBL1660371,Antimicrobial activity against erythromycin-susceptible Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
62879,,,5184932,[],CHEMBL1660368,Antimicrobial activity against erythromycin-susceptible Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62880,,,5184933,[],CHEMBL1660373,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group C clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
62881,,,5184934,[],CHEMBL1660370,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group G clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.5
62882,,,5184935,[],CHEMBL1660367,Antimicrobial activity against erythromycin-nonsusceptible Streptococcus Group F clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612313,Streptococcus,Streptococcus,1301.0,,,MIC90,ug ml-1,UO_0000274,,0.5
62883,,,5184983,[],CHEMBL1652892,Antimicrobial activity against Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62884,,,5184984,[],CHEMBL1652894,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62885,,,5184985,[],CHEMBL1652896,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62886,,,5184986,[],CHEMBL1652898,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,1.0
62887,,,5186017,[],CHEMBL1652898,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1649268,Antimicrob Agents Chemother,2009.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322874,>,1,1,>,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
62888,,,5194872,[],CHEMBL1671526,Antibacterial activity against Streptococcus hemolyticus 1002 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,32.0
62889,,,5194893,[],CHEMBL1671527,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
62890,,,5194914,[],CHEMBL1671528,Antibacterial activity against Escherichia coli 10-02 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
62891,,,5194935,[],CHEMBL1671529,Antibacterial activity against Klebsiella pneumoniae 10-1 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,32.0
62892,,,5194956,[],CHEMBL1671530,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
62893,,,5194977,[],CHEMBL1671531,Antibacterial activity against Pseudomonas aeruginosa 10-1 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
62894,,,5206323,[],CHEMBL1671222,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
62895,,,5206344,[],CHEMBL1671223,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-04 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
62896,,,5206365,[],CHEMBL1671224,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-05 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
62897,,,5206386,[],CHEMBL1671225,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-4 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,2.0
62898,,,5206407,[],CHEMBL1671226,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-5 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
62899,,,5206428,[],CHEMBL1671525,Antibacterial activity against Streptococcus pneumoniae 1001 after 18 to 24 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1667809,Bioorg Med Chem Lett,2011.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1329322,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
62900,,,5209464,[],CHEMBL1678307,Antimicrobial activity against Escherichia coli MG1655 after 24 hrs by modified broth macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332588,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.016
62901,,,5209465,[],CHEMBL1678305,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ASAU021 after 24 hrs by modified broth macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332588,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
62902,,,5209466,[],CHEMBL1678306,Antimicrobial activity against recA-deficient Staphylococcus aureus ASAU022 after 24 hrs by modified broth macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332588,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
62903,,,5209467,[],CHEMBL1678308,Antimicrobial activity against recA-deficient Escherichia coli MG1655 after 24 hrs by modified broth macrodilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332588,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.004
62904,,,5209468,[],CHEMBL1678309,"Antimicrobial activity methicillin-resistant against Staphylococcus aureus ASAU021 harboring gyrA S84A, S84L, S84P, E88G and E88K mutant recovered from compound supplemented plates after 24 hrs by modified broth macrodilution method relative to wild type",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332588,>,1,0,>,,FC,,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,4.0
62905,,,5209469,[],CHEMBL1678310,"Antimicrobial activity against Escherichia coli MG1655 harboring gyrA S84A, S83L, D87G, D87Y mutant recovered from compound supplemented plates after 24 hrs by modified broth macrodilution method relative to wild type",F,,,BAO_0000179,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332588,=,1,0,=,,FC,,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,8.0
62906,,Active,5209470,[],CHEMBL1678311,Bactericidal activity against recA-deficient Staphylococcus aureus ASAU022 assessed as induction of slow growth rate at 0.5 times MIC by time kill study,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332588,,1,0,,,Inhibition,%,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,INH,,UO_0000187,,
62907,,Active,5209471,[],CHEMBL1678312,Bactericidal activity against recA-deficient Staphylococcus aureus ASAU022 assessed as induction of increase bacterial kill rate at 2 times MIC by time kill study,F,,,BAO_0000201,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1332588,,1,0,,,Inhibition,%,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,INH,,UO_0000187,,
62908,,Active,5209472,[],CHEMBL1678313,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ASAU021 infected in in vitro hollow fiber infection model assessed as suppression of microbial resistance at AUC/MIC ratio of >32,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332588,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
62909,,Active,5209473,[],CHEMBL1678314,Antimicrobial activity against recA-deficient Staphylococcus aureus ASAU022 infected in in vitro hollow fiber infection model assessed as suppression of microbial resistance at AUC/MIC ratio of >23,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332588,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
62910,,Active,5209474,[],CHEMBL1678315,Antimicrobial activity against recA-deficient Staphylococcus aureus ASAU022 infected in in vitro hollow fiber infection model assessed as suppression of microbial resistance at AUC/MIC ratio of 31,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671737,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332588,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
62911,,,5209824,[],CHEMBL1678977,Antimicrobial activity against ESBL producing Escherichia coli isolated from patient bloodstream assessed as resistant isolate by Etest method,F,,,BAO_0001103,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671616,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://qudt.org/vocab/unit#Percent,1331735,=,1,0,=,,Activity,%,,92.2,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,92.2
62912,,,5210727,[],CHEMBL1676035,Ratio of MIC for wild type Pseudomonas aeruginosa PAO1 to Pseudomonas aeruginosa PAO1 horboring gabD mutant gene,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332597,=,1,0,=,,Ratio,,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Ratio,,,,8.0
62913,,,5210728,[],CHEMBL1676036,Ratio of MIC for wild type Pseudomonas aeruginosa PAO1 to Pseudomonas aeruginosa PAO1 horboring yaaA mutant gene,F,,,BAO_0000193,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332597,=,1,0,=,,Ratio,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Ratio,,,,2.0
62914,,,5210741,[],CHEMBL1677626,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as viable bacterial count by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
62915,,,5210742,[],CHEMBL1676040,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gatA::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
62916,,,5210743,[],CHEMBL1676041,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring phoU::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
62917,,,5210744,[],CHEMBL1676042,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gabD::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
62918,,,5210745,[],CHEMBL1676043,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring mmsA::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
62919,,,5210746,[],CHEMBL1676044,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring yaaA::ISphoA/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
62920,,,5210747,[],CHEMBL1676045,Antibacterial activity against Pseudomonas aeruginosa PAO1 harboring gabD::ISlacZ/haha mutation by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671741,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332597,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
62921,,,5210779,[],CHEMBL1676046,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB018 with PFGE subgroup G containing carbapenemase OXA-58 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,6.0
62922,,,5210785,[],CHEMBL1676047,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB039 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,8.0
62923,,,5210791,[],CHEMBL1676048,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB095 with PFGE subgroup E containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62924,,,5210797,[],CHEMBL1676049,Antibacterial activity against intI1-positive tigecycline-susceptible Acinetobacter baumannii AB110 with PFGE subgroup C containing carbapenemase OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,12.0
62925,,,5210803,[],CHEMBL1676050,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB127 with PFGE subgroup I containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62926,,,5210809,[],CHEMBL1676051,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB166 with PFGE subgroup A3 containing carbapenemase OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62927,,,5210815,[],CHEMBL1676052,Antibacterial activity against intI1-negative tigecycline-intermediate Acinetobacter baumannii AB098 with PFGE subgroup F containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62928,,,5210821,[],CHEMBL1676053,Antibacterial activity against intI1-positive tigecycline-intermediate Acinetobacter baumannii AB099 with PFGE subgroup H containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62929,,,5210827,[],CHEMBL1676054,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB106 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62930,,,5210833,[],CHEMBL1676055,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB113 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62931,,,5210839,[],CHEMBL1676056,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB118 with PFGE subgroup B2 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62932,,,5210845,[],CHEMBL1676057,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB125 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62933,,,5210851,[],CHEMBL1676058,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB134 with PFGE subgroup A2 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62934,,,5210857,[],CHEMBL1676059,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB168 with PFGE subgroup A1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62935,,,5210863,[],CHEMBL1676060,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB173 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62936,,,5210869,[],CHEMBL1676061,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB097 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62937,,,5210875,[],CHEMBL1676062,Antibacterial activity against intI1-positive tigecycline-resistant Acinetobacter baumannii AB096 with PFGE subgroup B1 containing carbapenemase OXA-23 and OXA-51 by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671742,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332606,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,32.0
62938,,,5210987,[],CHEMBL1679717,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 9 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62939,,,5210988,[],CHEMBL1679719,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 10 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62940,,,5210989,[],CHEMBL1679721,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 11 expressing ompA, adeB, adeM, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62941,,,5210990,[],CHEMBL1679723,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 12 expressing ompA, adeB, adeM, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62942,,,5210991,[],CHEMBL1679725,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 13 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62943,,,5210992,[],CHEMBL1679727,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 14 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62944,,,5210993,[],CHEMBL1679729,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 15 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62945,,,5210994,[],CHEMBL1679731,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 16 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62946,,,5210995,[],CHEMBL1679733,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 17 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62947,,,5210996,[],CHEMBL1679863,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii beta clonal group isolate 18 expressing ompA, adeB, adeM, aacA4, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62948,,,5210997,[],CHEMBL1679869,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 21 expressing ampC, ompA, adeB, adeM, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62949,,,5210998,[],CHEMBL1680767,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii unique clonal group isolate 40 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62950,,,5211027,[],CHEMBL1678986,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 2 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62951,,,5211028,[],CHEMBL1678987,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 3 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62952,,,5211029,[],CHEMBL1678988,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 4 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62953,,,5211030,[],CHEMBL1678989,"Antimicrobial activity against Acinetobacter baumannii alpha clonal group isolate 5 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62954,,,5211031,[],CHEMBL1680749,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 31 expressing ampC, ompA, adeB, adeM, aadB, aadA2 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62955,,,5211032,[],CHEMBL1680751,"Antimicrobial activity against Acinetobacter baumannii nu clonal group isolate 32 expressing ampC, ompA, adeB, adeM, aadB, aadA2 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62956,,,5211065,[],CHEMBL1680757,"Antimicrobial activity against Acinetobacter baumannii eta clonal group isolate 35 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,6.0
62957,,,5211066,[],CHEMBL1680759,"Antimicrobial activity against Acinetobacter baumannii eta clonal group isolate 36 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,>,1,1,>,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,6.0
62958,,,5211075,[],CHEMBL1680765,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 39 expressing ampC, ompA, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,0.09,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.09
62959,,,5211077,[],CHEMBL1680763,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 38 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.13
62960,,,5211134,[],CHEMBL1680600,"Antimicrobial activity against Acinetobacter baumannii lambda clonal group isolate 27 expressing ampC, ompA, adeB, adeM, aadB, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,3.0
62961,,,5211155,[],CHEMBL1678991,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 6 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,6.0
62962,,,5211156,[],CHEMBL1679713,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 7 expressing ampC, ompA, adeB, adeM, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,6.0
62963,,,5211157,[],CHEMBL1680761,"Antimicrobial activity against Acinetobacter baumannii unique clonal group isolate 37 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,6.0
62964,,,5211160,[],CHEMBL1680602,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 28 expressing ampC, ompA, adeM, aadB, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
62965,,,5211161,[],CHEMBL1680745,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 29 expressing ampC, ompA, adeM, aadB, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
62966,,,5211166,[],CHEMBL1679873,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 23 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, aphA6 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62967,,,5211176,[],CHEMBL1678981,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 1 expressing ampC, ompA, adeB, adeM by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
62968,,,5211177,[],CHEMBL1679871,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 22 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
62969,,,5211178,[],CHEMBL1680747,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii lambda clonal group isolate 30 expressing ampC, ompA, adeB, adeM, aadB, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
62970,,,5211198,[],CHEMBL1679715,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii alpha clonal group isolate 8 expressing ampC, ompA, adeB, adeM, aacC1, aadA1 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
62971,,,5211278,[],CHEMBL1679865,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 19 expressing ampC, ompA, adeB, adeM, aacC2 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62972,,,5211279,[],CHEMBL1679867,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 20 expressing ampC, ompA, adeB, adeM, aacC2 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,12.0
62973,,,5211290,[],CHEMBL1679875,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 24 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
62974,,,5211291,[],CHEMBL1679877,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 25 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
62975,,,5211292,[],CHEMBL1679879,"Antimicrobial activity against ISAba1 linked with the blaOXA-51-type beta-lactamase harboring Acinetobacter baumannii zeta clonal group isolate 26 expressing ampC, ompA, adeB, adeM, aadA1, aacA4, aacC2, blaSHV-5 by Etest method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671617,Antimicrob Agents Chemother,2008.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331742,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
62976,,,5211828,[],CHEMBL1678783,"Antimicrobial activity against Escherichia coli isolate 157 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 3 isolated from urine of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62977,,,5211829,[],CHEMBL1678784,Antimicrobial activity against Escherichia coli isolate 157T expressing beta-lactamase KPC2 and PFGE cluster 3 isolated from urine of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62978,,,5211830,[],CHEMBL1678785,"Antimicrobial activity against Escherichia coli isolate 329 expressing beta-lactamase KPC2, CTX-M-2, TEM and PFGE cluster 2 isolated from blood of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62979,,,5211831,[],CHEMBL1678786,Antimicrobial activity against Escherichia coli isolate 329T expressing beta-lactamase KPC2 and PFGE cluster 2 isolated from blood of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62980,,,5211832,[],CHEMBL1674594,"Antimicrobial activity against Escherichia coli isolate 339 expressing beta-lactamase KPC2, TEM and PFGE cluster 5 isolated from peritoneal fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62981,,,5211833,[],CHEMBL1674595,Antimicrobial activity against Escherichia coli isolate 339T expressing beta-lactamase KPC2 and PFGE cluster 5 isolated from peritoneal fluid of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62982,,,5211834,[],CHEMBL1674596,"Antimicrobial activity against Escherichia coli isolate 360 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from urine of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62983,,,5211835,[],CHEMBL1674597,"Antimicrobial activity against Escherichia coli isolate 360T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from urine of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62984,,,5211836,[],CHEMBL1674598,"Antimicrobial activity against Escherichia coli isolate 386 expressing beta-lactamase KPC2, CTX-M-15, OXA-9, TEM and PFGE cluster 1 isolated from wound of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62985,,,5211837,[],CHEMBL1674599,"Antimicrobial activity against Escherichia coli isolate 386T expressing beta-lactamase KPC2, OXA-9 and PFGE cluster 1 isolated from wound of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62986,,,5211838,[],CHEMBL1674600,"Antimicrobial activity against Escherichia coli isolate 540 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62987,,,5211839,[],CHEMBL1674601,"Antimicrobial activity against Escherichia coli isolate 543 expressing beta-lactamase KPC2, CTX-M-15, TEM and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62988,,,5211840,[],CHEMBL1674602,Antimicrobial activity against Escherichia coli isolate 543T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from synovial fluid of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62989,,,5211841,[],CHEMBL1674603,"Antimicrobial activity against Escherichia coli isolate 544 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from abscess of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62990,,,5211842,[],CHEMBL1674604,"Antimicrobial activity against Escherichia coli isolate 547 expressing beta-lactamase KPC2, TEM and PFGE cluster 4 isolated from blood of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62991,,,5211843,[],CHEMBL1674605,Antimicrobial activity against Escherichia coli isolate 547T expressing beta-lactamase KPC2 and PFGE cluster 4 isolated from blood of patient by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62992,,,5211844,[],CHEMBL1674606,"Antimicrobial activity against Escherichia coli isolate 1679 expressing beta-lactamase KPC2, SHV-12, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
62993,,,5211845,[],CHEMBL1674607,"Antimicrobial activity against Escherichia coli isolate 1679T expressing beta-lactamase KPC2, TEM and PFGE cluster 6 isolated from peritoneal fluid of patient by vitek-2 method",F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62994,,,5211846,[],CHEMBL1674608,Antimicrobial activity against Escherichia coli DH10B by vitek-2 method,F,,,BAO_0002146,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671686,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332142,<,1,1,<,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
62995,,,5212012,[],CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332160,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,1.0
62996,,Not Active,5212326,[],CHEMBL1673527,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2301 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332671,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
62997,,Not Active,5212336,[],CHEMBL1673521,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2403 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332671,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
62998,,Not Active,5212343,[],CHEMBL1675242,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 761 obtained from pus of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332671,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
62999,,Not Determined,5212353,[],CHEMBL1675236,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 625 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,,,BAO_0000375,BAO_0000218,organism-based format,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O,,,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,,CHEMBL5315124,LEVOFLOXACIN,CHEMBL33,,0,,1332671,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
